Can-Fite BioPharma (CANF) Receivables - Net (2013 - 2020)

Can-Fite BioPharma (CANF) has 6 years of Receivables - Net data on file, last reported at $3.6 million in Q2 2020.

• For the quarter ending Q2 2020, Receivables - Net changed N/A year-over-year to $3.6 million; the trailing twelve-month figure through Jun 2020 stood at $3.6 million (changed N/A YoY), and the FY2019 full-year result was $4.4 million, up 9.17% from the prior year.
• Receivables - Net was $3.6 million for Q2 2020 at Can-Fite BioPharma, down from $4.4 million in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $4.4 million in Q4 2019 to a low of $3.6 million in Q2 2020.
• A 3-year average of $4.0 million and a median of $4.0 million in 2018 frame the typical range for Receivables - Net.
• The largest YoY upside for Receivables - Net was 9.17% in 2019 against a maximum downside of 9.17% in 2019.
• Can-Fite BioPharma's Receivables - Net stood at $4.0 million in 2018, then climbed by 9.17% to $4.4 million in 2019, then decreased by 18.62% to $3.6 million in 2020.
• Per Business Quant data, the three most recent Receivables - Net figures were $3.6 million in Q2 2020, $4.4 million in Q4 2019, and $4.0 million in Q4 2018.